Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 269.42
-1.09 (-0.40%)
Mar 28, 2025, 7:22 PM BST
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 26.85 billion as of March 31, 2025. Its market cap has increased by 83.80% in one year.
Market Cap
26.85B
Enterprise Value
26.88B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
269.42
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 26.85B, an increase of 42,361.29%. That is a compound annual growth rate of 33.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.02B |
| GSK plc | 60.68B |
| Haleon | 35.23B |
| Smith & Nephew | 9.36B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.24B |